Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.

MLA

Zhou, Maggie, et al. “Feasibility of Longitudinal CtDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.” Cancers, vol. 15, no. 1, Dec. 2022. EBSCOhost, https://doi.org/10.3390/cancers15010157.

APA

Zhou, M., Bui, N., Rathore, R., Sudhaman, S., George, G. V., Malashevich, A. K., Malhotra, M., Liu, M. C., Aleshin, A., & Ganjoo, K. N. (2022). Feasibility of Longitudinal ctDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma. Cancers, 15(1). https://doi.org/10.3390/cancers15010157

Chicago

Zhou, Maggie, Nam Bui, Richa Rathore, Sumedha Sudhaman, Giby V George, Allyson K Malashevich, Meenakshi Malhotra, Minetta C Liu, Alexey Aleshin, and Kristen N Ganjoo. 2022. “Feasibility of Longitudinal CtDNA Assessment in Patients with Uterine and Extra-Uterine Leiomyosarcoma.” Cancers 15 (1). doi:10.3390/cancers15010157.